reports
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Clas...
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; o...
Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financ...
Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23 NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the fourth quarter and full year 2025 on Monday, February 23, 2026, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update...
The Simply Good Foods Company Reports CEO Inducement Grant Under Nasda...
The Simply Good Foods Company Reports CEO Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DENVER, Jan. 23, 2026 (GLOBE NEWSWIRE) -- On January 20, 2026, The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”) announced that Joseph E. Scalzo joined the Company in the role of President and Chief Executive Officer, effective January 19, 2026. Pursuant to the terms of his employment agreement, on January 19, 2026 and in connection with Mr. Scalzo’s appointment, the Company granted to Mr. Scalzo an option to purchase 2,000,000 shares of the Company's common st...
Simply Good Foods Appoints Joe Scalzo as President and Chief Executive...
Simply Good Foods Appoints Joe Scalzo as President and Chief Executive Officer Key Architect and Longtime Former CEO and Executive Vice Chairman of Simply Good Foods Returns to Lead New Chapter of Growth DENVER, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced the return and appointment of longtime former executive Joe Scalzo as President and Chief Executive Officer. Mr. Scalzo will oversee a new chapter at Simply Good Foods focused on reigniting growth an...
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the ...
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced the first patient has been dosed in the FORWARD Phase 3 trial of AXS-14 (esreboxetine) for the management of fibromyalgia. FORWARD (Fibromyalgia Response with Esreboxetine Evaluated Using a Randomized Withdrawal Research Design) is a Phase 3, double-blind, placebo-controlled, multicenter,...
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year ...
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue Total preliminary 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively, representing 65% and 66% annual growth, respectively AUVELITY® preliminary 4Q and full year 2025 net product sales of $155.1 million and $507.1 million, respectively SUNOSI® preliminary 4Q and full year 2025 net product revenue of $36.7 million and $124.8 million, respectively SYMBRAVO® preliminary 4Q and full year 2025 net product sales of $4.1 million and $6.6 million, respectively...
The Simply Good Foods Company Reports Fiscal First Quarter 2026 Finan...
The Simply Good Foods Company Reports Fiscal First Quarter 2026 Financial Results and Reaffirms Fiscal Year 2026 Outlook DENVER, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen weeks ended November 29, 2025. First Quarter Summary:(1) Net sales of $340.2 million versus $341.3 millionNet income of $25.3 million versus $38.1 millionEarnings per diluted share (“EPS”) of $0.26 versus $0.38Adjusted Diluted EPS(2) of $0.39...
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare C...
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, January 14th at 1:30 p.m. Pacific time. The fireside chat will be webcast live and available for replay in the Investors sectio...
Axsome Therapeutics Announces FDA Acceptance and Priority Review of Su...
Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s supplemental New Drug Application (NDA)...
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 i...
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has received formal pre-New Drug Application (NDA) meeting minutes from the U.S. Food and Drug Administration (FDA) supporting an NDA submission for AXS-12 in narcolepsy. AXS-12 (reboxetine) is a highly se...
- Jonathan Moreland
Simply Good Foods to Report First Quarter Fiscal Year 2026 Financial R...
Simply Good Foods to Report First Quarter Fiscal Year 2026 Financial Results on Thursday, January 8, 2026 DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced it will report financial results for the first quarter of Fiscal Year 2026 on Thursday, January 8, 2026. A press release will be issued that morning, followed by a live conference call beginning at 6:30 a.m. Mountain Time (8:30 a.m. Eastern Time). Participating on the call will be Geoff Tanner, Pre...
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
RPM RPM INTERNATIONAL INC.
UNVA UNILEVER PLC ADS
LNG CHENIERE ENERGY INC.
WDAY WORKDAY INC. CLASS A
SYY SYSCO CORPORATION
SLGN SILGAN HOLDINGS INC.
SLF. SUN LIFE FINANCIAL INC.
POST POST HOLDINGS INC.
PG PROCTER & GAMBLE COMPANY
OMC OMNICOM GROUP INC
MKTX MARKETAXESS HOLDINGS INC.
MKC MCCORMICK & COMPANY INCORPORATED
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
LOPE GRAND CANYON EDUCATION INC.
GIS GENERAL MILLS INC.
CPB CAMPBELL SOUP COMPANY
CHD CHURCH & DWIGHT CO. INC.
CALM CAL-MAINE FOODS INC.
CAG CONAGRA BRANDS INC.
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
AMSF AMERISAFE INC.
NFLX NETFLIX INC.
EFX. ENERFLEX
STN. STANTEC INC
BRO BROWN & BROWN INC.
MSM MSC INDUSTRIAL DIRECT CO. INC. CLASS A
AJG ARTHUR J. GALLAGHER & CO.
RDED RELX PLC
NTNX NUTANIX INC. CLASS A
TRNS TRANSCAT
KNSL KINSALE CAPITAL GROUP INC.
WDFC WD-40 COMPANY
AXON AXON ENTERPRISE INC
CRVL CORVEL CORP.
ZLAB ZAI LAB LTD. SPONSORED ADR
SMPL SIMPLY GOOD FOODS CO
ABT ABBOTT LABORATORIES
ZS ZSCALER INC.
SPOT SPOTIFY TECHNOLOGY SA
IIIV I3 VERTICALS
VITL VITAL FARMS
LI LI AUTO INC. SPONSORED ADR CLASS A
OTIS OTIS WORLDWIDE CORPORATION
TT TRANE TECHNOLOGIES PLC
2VZ LEONARDO DRS INC.
SKWD SKYWARD SPECIALTY INS GROUP INC
LIN LINDE PUBLIC LIMITED COMPANY
ASPI ASP ISOTOPES INC
TRI THOMSON REUTERS CORPORATION
TXO TXO PARTNERS L.P.
WAY WAYSTAR HOLDING CORP
- Jonathan Moreland
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP
TPC TUTOR PERINI CORPORATION
SLGN SILGAN HOLDINGS INC.
RPD RAPID7 INC.
OPK OPKO HEALTH INC.
OHI OMEGA HEALTHCARE INVESTORS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MTDR MATADOR RESOURCES COMPANY
GBCI GLACIER BANCORP INC.
FTAI FORTRESS TRANSPORTATION AND INFRASTRUCTURE INVESTORS LLC
FOXF FOX FACTORY HOLDING CORP.
EIG EMPLOYERS HOLDINGS INC.
ARCC ARES CAPITAL CORPORATION
RLMD RELMADA THERAPEUTICS
TREX TREX COMPANY INC.
VVV VALVOLINE INC.
KREF KKR REAL ESTATE FINANCE TRUST
HLNE HAMILTON LANE INCORPORATED CLASS A
SONO SONOS
VRCA VERRICA PHARMACEUTICALS
AMCR AMCOR PLC
AVTR AVANTOR
TSLX INC.
VLA SIXTH STREET SPECIALTY LENDING
MRVI INC.
FRSH ARBOR METALS
SG MARAVAI LIFESCIENCES HOLDINGS
TBBK FRESHWORKS INC.
QDEL SWEETGREEN INC
BHVN THE BANCORP
WEST INC.
SMRT QUIDEL CORP
CRVO BIOHAVEN LTD
NCDL WESTROCK COFFEE COMPANY LLC
GAM SMARTRENT INC
STRZ CERVOMED INC
GMRE NUVEEN CHURCHILL DIRECT LENDING CORP
OESX GENERAL DE ALQUILER DE MAQUINARIA
STARZ ENTERTAINMENT CORP
GLOBAL MEDICAL REIT INC.
ORION ENERGY SYSTEMS INC
- Jonathan Moreland
UEC URANIUM ENERGY CORP
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP
STAA STAAR SURGICAL CO.
OPK OPKO HEALTH INC.
LQDT LIQUIDITY SERVICES
LMAT LEMAITRE VASCULAR INC.
FAST FASTENAL COMPANY
BEN FRANKLIN RESOURCES INC.
SRTS SENSUS HEALTHCARE
RSSS RESEARCH SOLUTIONS
ULBI ULTRALIFE
EVLV EVOLV TECHNOLOGIES HLDGS INC
WEST WESTROCK COFFEE COMPANY LLC
SMRT SMARTRENT INC
NCDL NUVEEN CHURCHILL DIRECT LENDING CORP
SLS SELLAS LIFE SCIENCES GROUP INC
BATRK LIBERTY MEDIA CORP
ANNX ANNEXIN PHARMACEUTICALS AB (PUBL)
OESX ORION ENERGY SYSTEMS INC
Opko Health Inc: 1 director
A director at Opko Health Inc bought 580,000 shares at 1.326USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- Jonathan Moreland
PPSI PIONEER POWER SOLUTIONS
PEB PEBBLEBROOK HOTEL TRUST
PCTY PAYLOCITY HOLDING CORP.
OPK OPKO HEALTH INC.
LOB LIVE OAK BANCSHARES
GOGO GOGO INC.
GLP GLOBAL PARTNERS LP
FLDM FLUIDIGM
FAST FASTENAL COMPANY
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
CNS COHEN & STEERS INC.
MSM MSC INDUSTRIAL DIRECT CO. INC. CLASS A
INTT INTEST CORP.
MIRM MIRUM PHARMACEUTICALS
TSLX SIXTH STREET SPECIALTY LENDING
MYPS INC.
QDEL PLAYSTUDIOS INC
GTE QUIDEL CORP
ET GRAN TIERRA ENERGY INC.
MXF ENERGY TRANSFER LP
GDV THE MEXICO FUND
INC.
THE GABELLI DIVIDEND & INCOME TRUST
Axsome Therapeutics to Participate in Upcoming Investor Conferences
Axsome Therapeutics to Participate in Upcoming Investor Conferences NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in December: Piper Sandler 37th Annual Healthcare Conference Fireside Chat: Wednesday, December 3, 2025, at 4:00 p.m. ET in New York, NY BofA Securities CNS Therapeutics Virtual Conference 2025 Fireside Chat: Monday, December 8, 2025, at 11:40...
- Jonathan Moreland
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP
OPK OPKO HEALTH INC.
HUBB HUBBELL INCORPORATED CLASS B
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
GAM GENERAL AMERICAN INVESTORS CO. INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
SRTS SENSUS HEALTHCARE
AEYE AUDIOEYE INC
UTZ UTZ BRANDS INC (A)
CRVO CERVOMED INC
NEXT NEXTSOURCE MATERIALS INC.
SPRU SPRUCE POWER HOLDING CORP
FG F AND G ANNUITIES AND LIFE
HYMC INC.
FIG HYCROFT MINING HOLDING CORPORATION
STRZ FIGMA INC.
CRCL STARZ ENTERTAINMENT CORP
BATRK CIRCLE INTERNET GROUP INC.
ANNX LIBERTY MEDIA CORP
ANNEXIN PHARMACEUTICALS AB (PUBL)
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare...
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Wednesday, December 3rd at 12:00 p.m. Eastern time. Investors interested in scheduling a meeting with OPKO management should conta...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.